Skip to main content
. 2012 Jan 16;35(2):218–225. doi: 10.2337/dc11-1109

Figure 2.

Figure 2

HRs (95% CIs) for total CVD events, cardiovascular mortality, and total mortality risk by treatment allocation within different categories of eGFR. ■, relative weights of the outcome event in each group; ⋄, summary HR with 95% CI.

HHS Vulnerability Disclosure